Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction

---
identifier: "/us/fr/2011-13871"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2011-13871"
section_name: "Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction"
positive_law: false
currency: "2011-06-06"
last_updated: "2011-06-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-13871"
document_type: "notice"
publication_date: "2011-06-06"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "76 FR 32367"
fr_volume: 76
docket_ids:
  - "Docket No. FDA-1999-D-0742 (formerly Docket No. 1999D-4396)"
fr_action: "Notice; correction."
---


#  Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of May 24, 2011 (76 FR 30175). The document announced the availability of a draft guidance entitled “ Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators.”The document was published with an incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2011-12623, appearing on page 30175, in the *Federal Register* of Tuesday, May 24, 2011, the following correction is made:

1. On page 30175, in the second column, in the Docket No. heading, “[Docket No. FDA-1999-D-0792] (Formerly FDA-1999-D-0792)” is corrected to read “[Docket No. FDA-1999-D-0742] (formerly Docket No. 1999D-4396)”.

Dated: May 31, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.